Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
Steigende Produktionsmengen, operative Hebelwirkung und der Goldpreis könnten zusammen neue Impulse setzen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
17 Leser
Artikel bewerten:
(0)

North America Ophthalmology Glaucoma Surgery Device Market is Expected to Reach $138.3 Million by 2019, at a CAGR of 7.8% From 2014 to 2019

FORT WORTH, Texas, May 5, 2015 /PRNewswire/ --

North American ophthalmology glaucoma surgery device market was valued at $94.9 million in 2014, and is estimated to grow to $138.3 million by 2019, at a CAGR of 7.8% from 2014 to 2019.

Browse through the TOC of North America Ophthalmology Glaucoma Surgery Device Market for an analysis of industry trends and segments, with the help of various tables and figures.

http://www.micromarketmonitor.com/market/north-america-glaucoma-surgery-devices-8830146604.html

Early buyers will receive 10% customization on this report.

Glaucoma is the second most common cause of blindness worldwide, and the leading cause of bilateral, irreversible blindness. It is characterized by the relatively high intraocular pressure (IOP) as a result of impaired drainage of a fluid, known as aqueous humor, from the eye. Currently, the approved treatments for glaucoma include a pharmaceutical drug, glaucoma laser therapies, and surgical procedures. It is estimated that by 2020, 11 million individuals will be blind due to glaucoma and around 10% of the people suffering from eye disorders will experience loss of vision in spite of proper treatment.

The North American ophthalmology glaucoma surgery devices market is driven by the growing incidences of ocular disorders, increased aging population, and rising prevalence of obesity and diabetes. However, lack of awareness among people regarding eye disorders and poor primary healthcare infrastructure are the major factors restraining the growth of ophthalmology glaucoma surgery devices market in this region.

The key players in the North American ophthalmology glaucoma surgery devices market are Abbott Laboratories (U.S.), Alcon, Inc. (Switzerland), Carl Zeiss Meditec AG (Germany), Nidek Co., Ltd. (U.S.), Lumenis Ltd. (Israel), Ellex Medical Lasers Ltd. (Australia), and IRIDEX Corporation (U.S.).

Speak toAnalyst @http://www.micromarketmonitor.com/contact/8830146604-speak_to_analyst.html

This market is segmented and forecast on the basis of types and end-users. The types comprise of glaucoma drainage devices (gdd), glaucoma implants and stents, glaucoma lasers, and glaucoma systems while the end-users include private eye clinics, hospitals, and other end-users.

The North American ophthalmology glaucoma surgery devices market is further segmented and forecast on the basis of major countries, including the U.S., Canada, and Mexico. This report also includes the market share, value chain analyses, and market metrics, such as drivers, restraints, and upcoming opportunities in the market. In addition, it presents a competitive landscape and company profiles of key market players.

Related Reports:

The Ophthalmology Surgery Devices Market was valued at $5,268.7 million in 2013 and is estimated to reach $7,401.4 million by 2018, at a CAGR of 7.0% for the forecast period. The cataract surgery device segment has accounted for the largest share, amounting to $4,152.0 million or approximately 80% of the total ophthalmology surgery device market.

http://www.micromarketmonitor.com/market-report/opthalmology-surgery-devices-reports-1741485395.html

Report Subscription:

MicroMarket Monitor produces exclusive market research reports, based on real-time data to provide better understanding of the dynamic market conditions of the Healthcare industry. The reports offer in-depth and complete analysis of the regional and country level marketplaces. The research reports for Healthcare industry are updated on quarterly basis and are easily available for purchase through annual subscriptions.

http://www.micromarketmonitor.com/offerings/subscription

About MicroMarket Monitor:

MicroMarket Monitor identifies and attends to various unmet needs of different industrial verticals, which include value chain impact analysis. The company publishes about 12000 Market Research Reports on various Micro Markets across the world. The graphical nature and multidimensional analysis of these reports provide advanced Business Intelligence Tools to the clients in that particular target market.

Contact:
Mr. Chandrasekhar K.
5601 Bridge Street
Suite 300
Fort Worth, TX 76112
Tel: +1-888-502-0539
Email: sales@micromarketmonitor.com

© 2015 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.